The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention have authorized the Moderna and Johnson & Johnson (Janssen) COVID-19 vaccines for boosters for eligible individuals.
What you can expect next
Eligible faculty and staff who received their second dose of an mRNA vaccine (Pfizer-BioNTech or Moderna) at least six months ago will receive an email invitation from University Employee Health Clinic when it is their time to book a vaccine booster dose appointment. From that email link, an appointment may be scheduled at a time when UEHC is offering the vaccine that is convenient for the employee.
Employees eligible for boosters will receive an email from the University Employee Health Clinic (UEHC) giving instructions for Ready Set survey completion and self-scheduling their booster appointments. Be sure to check your email for this message. Employees may need to check their junk mail to find their notification email from UEHC.
- A “booster dose” refers to another dose of a vaccine that is given to someone who built enough protection after vaccination, but then that protection decreased over time (this is called waning immunity).
- If you haven’t yet received a COVID-19 vaccine, there’s still time for you to be protected. And scheduling your vaccination is easy. Just call the University Employee Health Clinic at 319-356-3631, option 3. You may also email email@example.com to request an appointment.
- You should still get vaccinated, even if you’ve already contracted COVID-19 and recovered from it. The natural immunity you receive after having COVID-19 is clearly enhanced by a COVID-19 vaccine.
COVID-19 vaccine boosters can further enhance or restore protection that might have waned over time after your primary series vaccination.
People are protected best from severe COVID-19 illness when they stay up to date with their COVID-19 vaccines, which includes a booster for many people.
Additionally, the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have authorized a second booster dose of these COVID-19 vaccines for adults ages 50 and older—and other select individuals—at least four months after receiving their first booster dose of any approved COVID-19 vaccine.
UEHC is offering first, second, and booster doses of the Pfizer-BioNTech and Moderna COVID-19 vaccines.
UEHC will not offer the Johnson & Johnson (Janssen) vaccine through the University Employee Health Clinic, though this vaccine is widely available through community pharmacies.
You can also receive your flu vaccination through UEHC, which can be administered at the same time as a COVID-19 vaccine.
Employees can schedule their booster (or first or second doses) of the COVID-19 vaccine through the University Employee Health Clinic (UEHC) by following the directions below.
You can also email UEHC UEHCReadySet@healthcare.uiowa.edu or call 319-356-3631 if you cannot self-schedule in ReadySet.
Yes, you can reach still receive the booster through UEHC by following the directions in the question above.
Yes, vaccines may be mixed and matched.
Your first booster does not need to match your primary vaccination series, nor does your second booster need to match your first booster. For example, you could have Johnson & Johnson as your primary vaccination series, Pfizer-BioNTech as your first booster, and Moderna as your second booster.
However, it is recommended that individuals receive the Pfizer-BioNTech or Moderna vaccines as a booster in most situations—regardless of the vaccine you received as part of your primary vaccination series.
If you have questions or concerns, please consult your primary care provider.
People who completed all of the recommended doses of a COVID-19 vaccine which is listed for emergency use by the WHO but is not approved or authorized by FDA, or people who completed a heterologous (mix and match) series composed of any combination of FDA-approved, FDA-authorized, or WHO emergency use listed COVID-19 vaccines:
- Are considered fully vaccinated.
- Under the Emergency Use Instructions (EUI), moderately or severely immunocompromised people aged ≥12 years should receive an additional primary dose of Pfizer-BioNTech COVID-19 Vaccine (30 µg formulation [purple cap]) at least 28 days after receiving the second vaccine dose of their primary series.
- Under the EUI, people aged ≥18 years (including moderately or severely immunocompromised people who received an additional primary dose) should receive a single booster dose of Pfizer-BioNTech COVID-19 Vaccine (30 µg formulation [purple cap]) at least 6 months after completing their primary series.
WHO has listed the following COVID-19 vaccines for emergency use:
- Pfizer-BioNTech COVID-19 Vaccine (e.g., BNT162b2, COMIRNATY, Tozinameran)
- AstraZeneca-Oxford COVID-19 Vaccine (e.g., [ChAdOx1-S (recombinant)], AZD1222, Covishield, Vaxzevria)
- Janssen (Johnson & Johnson) COVID-19 Vaccine (e.g., Ad26.COV2.S)
- Moderna COVID-19 Vaccine (e.g., mRNA 1273, Takeda, Spikevax)
- Sinopharm-BIBP COVID-19 Vaccine
- Sinovac-CoronaVac COVID-19 Vaccine
- Bharat Biotech International COVID-19 Vaccine (e.g., BBV152, COVAXIN)
Please remember to bring your employee ID badge and your vaccination card with you to your appointment.
- Arm pain
No. However, it is important you update your COVID-19 Immunization Survey in ReadySet to indicate that you have received your booster elsewhere.
Hourly employees and non-exempt employees, who normally badge in ELMS, will be paid for the time spent receiving the vaccine through the University Employee Health Clinic. There is a badge reader located in the vaccination clinic.
You can view the date of your last COVID-19 vaccination on your COVID-19 vaccine card.
If you received your initial COVID-19 vaccinations through the University Employee Health Clinic, you can also view this information by logging into ReadySet. Once in ReadySet, choose “Results” under Test Results on the left-hand menu. In the list to the right, choose “COVID-19 (SARS-COV-2) IMMUNIZATION RECORD,” and “Date vaccine administered,” and in the middle of the page it will show the date it was received.
You are considered fully vaccinated two weeks after completing a two dose mRNA vaccine series (like the Pfizer-BioNTech or Moderna vaccines), or two weeks after the one dose Johnson & Johnson (Janssen) vaccine.
Sometimes people who are moderately to severely immunocompromised do not build enough protection when they first get a vaccination. When this happens, getting another dose of the vaccine can sometimes help them build more protection against the disease.
This appears to be the case for some immunocompromised people and COVID-19 vaccines. In these cases, the additional dose is considered part of their original COVID-19 vaccination series. Certain immunocompromised individuals require three doses of the Pfizer-BioNTech or Moderna vaccines as their primary series instead of the two doses required by the general population. Similarly, certain immunocompromised individuals require two doses of the Johnson & Johnson (Janssen) vaccine as their primary series, instead of the one dose required by the general population.
In contrast, a “booster dose” refers to another dose of a vaccine given to someone who built enough protection after their primary COVID-19 vaccination series (two doses of Pfizer-BioNTech/Moderna or one dose of Johnson & Johnson). Over time, immunity provided by the vaccines starts to decrease—something known as “waning immunity.” Booster doses are administered to re-strengthen immunity against the COVID-19 virus.
If you are age 18 or older and received an additional dose of the Moderna vaccine, or age 12 years or older and received an additional dose of the Pfizer-BioNTech COVID-19 vaccine, you are eligible for boosters.